Medicago Entering Letter Of Intent With Tabuk Pharma

Canadian vaccine maker Medicago has produced a Letter of Intent (LOI) with one of the largest pharmaceutical firms in Saudi Arabia, Tabuk Pharma. The agreement will now move both firms into negotiations over the commercialisation of Medicago's vaccines in Saudi Arabia, leveraging Tabuk's strong presence and distribution networks to maximise sales in the country.

To read the full article, please choose one of the following options: